Literature DB >> 7650928

Pancreatic insulin-secreting carcinoma in a dog: fructosamine for determining persistent hypoglycaemia.

S I Thoresen1, M Aleksandersen, L Lønaas, W P Bredal, J Grøndalen, K Berthelsen.   

Abstract

A five-year-old intact male rottweiler was presented with a history of episodic weakness and mild-generalised seizures. A tentative diagnosis of an insulin-secreting tumour in the pancreas was made based on fasting hypoglycaemia with concomitant hyperinsulinaemia and a subnormal fructosamine value. The diagnosis was confirmed by exploratory coeliotomy, intravenous infusion of methylene blue, histopathology and immuno-histochemical analysis of suspected neoplastic tissue. Fructosamine assays are traditionally used for monitoring the metabolic status of diabetics where a single elevated measurement reflects persistent hyperglycaemia. This report suggests that a single low measurement of fructosamine may indicate persistent hypoglycaemia and may be helpful, in conjunction with an insulin measurement, in the diagnosis of insulin-secreting tumours.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650928     DOI: 10.1111/j.1748-5827.1995.tb02921.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  4 in total

1.  Evolution of fructosaminaemia and glucaemia during the growth of unweaned and early weaned half-bred zebu calves.

Authors:  J A Coppo
Journal:  Vet Res Commun       Date:  2001-08       Impact factor: 2.459

2.  Serum fructosamine: a reference interval for a heterogeneous canine population.

Authors:  J A Coppo; N B Coppo
Journal:  Vet Res Commun       Date:  1997-10       Impact factor: 2.459

3.  An evaluation of serum fructosamine as a marker of the duration of hypoproteinaemic conditions in dogs.

Authors:  S I Thoresen; W P Bredal
Journal:  Vet Res Commun       Date:  1998-04       Impact factor: 2.459

4.  Clinical value of fructosamine measurements in non-healthy dogs.

Authors:  A Loste; M C Marca; M Pérez; A Unzueta
Journal:  Vet Res Commun       Date:  2001-02       Impact factor: 2.459

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.